Company: FORA
Filing Date: 2025-12-04
Form Type: PRE 14A
Source: 0001140361-25-044359
Chunk: 47

Company: Forian Inc.
Filing Date: 2025-12-04
Form: PRE 14A
Chunk 47
---
 OF THE SPECIAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING TO APPROVE**

#### PROPOSAL 1.
<div align='center'>36</div>

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS AND OFFICERS The following table sets forth certain information known to us regarding the beneficial ownership of our Common Stock as of November 26, 2025 (except where otherwise noted) by:

| • | each stockholder known by the Company to own beneficially more than 5% of our Common Stock; |

| • | each of our named executive officers; |

| • | each of our directors; and |

| • | all directors and executive officers as a group. |

Percentage ownership in the following table is based on 31,072,252 shares of Common Stock outstanding as of November 26, 2025. We have determined beneficial ownership in the table in accordance with the rules of the SEC. In computing the number of shares beneficially owned by any person or group of persons and the percentage ownership of that person or group, shares of Common Stock that may be acquired within 60 days of November 26, 2025, subject to options or other rights held by such person, are deemed to be beneficially owned by such person and outstanding for the calculation of such person’s percentage ownership. These shares are not considered to be outstanding for computing the percentage ownership of any other person. Unless otherwise noted, the address of all listed stockholders is c/o Forian Inc., 41 University Drive, Suite 400, Newtown, PA 18940. To our knowledge, each stockholder identified in the table possesses sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned by such stockholder unless noted otherwise, subject to community property laws where applicable.

| Name of Beneficial Owner                                         |     |  Number of 
  Shares of 
     Common 
      Stock |     | Percentage 
 of         
 Class      |
| Named Executive Officers and Directors:                          |     |            |     |            |
| Mark J. Adler, M.D.(1)                                           |     |     73,833 |     | *          |
| Ian G. Banwell(2)                                                |     |    142,284 |     | *          |
| Adam Dublin                                                      |     |  2,405